The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables
1993

TP53 Gene Loss in Colorectal Cancer

Sample size: 231 publication Evidence: high

Author Information

Author(s): G.I. Meling, R.A. Lothe, A.-L. B0rresen, C. Graue, S. Haugel, O.P.F. Clausen, T.O. Rognum

Primary Institution: The National Hospital, University of Oslo

Hypothesis

What is the relationship between TP53 gene loss and DNA ploidy pattern in colorectal carcinomas?

Conclusion

The study found a strong association between TP53 gene loss and DNA aneuploidy in colorectal carcinomas.

Supporting Evidence

  • Loss of the TP53 gene was found in 68% of colorectal carcinomas.
  • TP53 gene loss was significantly associated with DNA aneuploidy.
  • 85% of highly DNA aneuploid tumours had TP53 gene loss.
  • TP53 gene loss was more frequent in moderately differentiated carcinomas.
  • Loss of TP53 gene increased significantly towards the distal part of the large bowel.

Takeaway

This study looked at how a specific gene related to cancer, called TP53, is lost in colorectal tumors and how that loss is linked to the tumor's DNA structure.

Methodology

The study analyzed fresh tissue samples from 231 patients with colorectal adenocarcinomas, examining the relationship between TP53 gene loss and DNA ploidy pattern.

Participant Demographics

{"male":{"percentage":52,"mean_age":68,"age_distribution":{"under_50":12,"over_50":88}},"female":{"percentage":48,"mean_age":69,"age_distribution":{"under_50":6,"over_50":94}}}

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication